BIOMAT Database Logo BIOMAT Database Logo

A novel, highly efficient peptide-HLA class I binding assay using unfolded heavy chain molecules: identification of HIV-1 derived peptides that bind to HLA-A*0201 and HLA-A*0301. 1997

T L Tan, and A Geluk, and M Toebes, and T H Ottenhoff, and J W Drijfhout
Department of Immunohematology and Blood Bank, Leiden University Hospital, Netherlands.

A novel cell-free, highly automated peptide-HLA binding assay has been designed during which a mixture of unfolded recombinant HLA heavy chain molecules, beta 2-microglobulin and a fluorescent labeled standard peptide is allowed to form peptide-HLA complexes. The binding of a peptide of interest is monitored as the ability to inhibit the formation of fluorescent peptide-HLA complexes. The assay was validated using published, known HLA-A* 0201 and HLA-A* 0301 binding peptides. In addition a selected set of HIV-1LAI reverse transcriptase derived 10-mer peptides, that had been selected on the basis of HLA-A* 0201 or HLA-A* 0301 binding motifs, were tested for HLA-A* 0201/A* 0301 binding. In that set we identified 8 peptides which bound with high affinity to HLA-A* 0201 and 5 peptides which bound with high affinity to HLA-A* 0301. The major advantage of the use of denatured heavy chain is the improved economy and efficiency, as unfolded protein material is in principle easily accessible by recombinant technology.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011489 Protein Denaturation Disruption of the non-covalent bonds and/or disulfide bonds responsible for maintaining the three-dimensional shape and activity of the native protein. Denaturation, Protein,Denaturations, Protein,Protein Denaturations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001613 beta 2-Microglobulin An 11-kDa protein associated with the outer membrane of many cells including LYMPHOCYTES. It is the small subunit of MHC CLASS I MOLECULES. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, CEREBROSPINAL FLUID, and urine of healthy individuals, and to a much greater degree in the urine and plasma of patients with tubular PROTEINURIA, renal failure, or kidney transplants. Thymotaxin,beta 2 Microglobulin
D015234 HLA-A Antigens Polymorphic class I human histocompatibility (HLA) surface antigens present on almost all nucleated cells. At least 20 antigens have been identified which are encoded by the A locus of multiple alleles on chromosome 6. They serve as targets for T-cell cytolytic responses and are involved with acceptance or rejection of tissue/organ grafts. Antigens, HLA-A,HLA-A,Antigens, HLA A,HLA A Antigens
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse

Related Publications

T L Tan, and A Geluk, and M Toebes, and T H Ottenhoff, and J W Drijfhout
An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301.
December 1995, Human immunology,
T L Tan, and A Geluk, and M Toebes, and T H Ottenhoff, and J W Drijfhout
Identification of five different Patr class I molecules that bind HLA supertype peptides and definition of their peptide binding motifs.
October 2000, Journal of immunology (Baltimore, Md. : 1950),
T L Tan, and A Geluk, and M Toebes, and T H Ottenhoff, and J W Drijfhout
Prediction of promiscuous peptides that bind HLA class I molecules.
June 2002, Immunology and cell biology,
T L Tan, and A Geluk, and M Toebes, and T H Ottenhoff, and J W Drijfhout
Identification of novel HIV-1-derived HLA-E-binding peptides.
October 2018, Immunology letters,
T L Tan, and A Geluk, and M Toebes, and T H Ottenhoff, and J W Drijfhout
Detailed motifs for peptide binding to HLA-A*0201 derived from large random sets of peptides using a cellular binding assay.
May 1995, Human immunology,
T L Tan, and A Geluk, and M Toebes, and T H Ottenhoff, and J W Drijfhout
Unfolded HLA class I alpha chains and their use in an assay of HLA class-I-peptide binding.
February 1993, Human immunology,
T L Tan, and A Geluk, and M Toebes, and T H Ottenhoff, and J W Drijfhout
Nucleophosmin leukaemic mutants contain C-terminus peptides that bind HLA class I molecules.
February 2008, Leukemia,
T L Tan, and A Geluk, and M Toebes, and T H Ottenhoff, and J W Drijfhout
Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2.
February 1994, Human immunology,
T L Tan, and A Geluk, and M Toebes, and T H Ottenhoff, and J W Drijfhout
Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(alpha 1*0501, beta 1*0201) molecule.
March 1994, International immunology,
T L Tan, and A Geluk, and M Toebes, and T H Ottenhoff, and J W Drijfhout
Direct binding of influenza peptides to class I HLA molecules.
February 1989, Nature,
Copied contents to your clipboard!